SCHEMBL369394

SCHEMBL369394

[CH2]C(C)N(CC=C)CC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL321521 0.79
SCHEMBL1137481 0.79 MEN1 (0.33)
Hydrochloric Acid SCHEMBL5269910 0.77 MEN1 (0.32)
Water SCHEMBL31456290 0.77 MEN1 (0.32)
SCHEMBL787268 0.74 MEN1 (0.32)
SCHEMBL370515 0.74
SCHEMBL7939314 0.74
SCHEMBL19330081 0.74
SCHEMBL12464312 0.74 MEN1 (0.32)
SCHEMBL10582934 0.74 MEN1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1802650-B1 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION SCYNEXIS INC (US) 2011-10-26 EP claimed
EP-1802650-A4 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION SCYNEXIS INC (US) 2008-08-20 EP claimed
EP-1802650-A2 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION Scynexis, Inc. (US) 2007-07-04 EP claimed
US-20060160727-A1 3-Ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection FLIRI HANS G 2006-07-20 US claimed
US-20060089301-A1 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection SCYNEXIS, INC. 2006-04-27 US claimed
WO-2006039668-A2 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION SCYNEXIS, INC (US) 2006-04-13 WO claimed
JP-3193379-B2 2001-07-30 JP claimed
EP-0626943-B1 BISTRIAZENES AS CHEMOTHERAPEUTIC AGENTS US HEALTH (US) 2000-01-26 EP claimed
US-5808038-A ANTICARCER AGENT THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1998-09-15 US claimed
EP-0626943-A1 BISTRIAZENES AS CHEMOTHERAPEUTIC AGENTS THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1994-12-07 EP claimed
WO-1993009089-A1 BISTRIAZENES AS CHEMOTHERAPEUTIC AGENTS THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1993-05-13 WO claimed
US-4980356-A ANTICONVULSANTS; ANTISPASMODIC AGENTS; MUSCULAR AND NERVOUS SYSTEMS DISORDERS RHONE-POULENC SANTE (FR) 1990-12-25 US claimed
CN-118324867-A Novel cyclosporin derivatives and uses thereof 美国科技环球有限公司 2024-07-12 CN disclosed
CN-109476705-B Novel cyclosporin derivatives and uses thereof 美国科技环球有限公司 2024-02-27 CN disclosed
EP-3831841-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T Global Inc. (US) 2021-06-09 EP disclosed
US-10647747-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2020-05-12 US disclosed
US-5026717-A Glutamate inhibitors RHONE-POULENC SANTE (FR) 1991-06-25 US disclosed
US-5026717-A Glutamate inhibitors RHONE-POULENC SANTE (FR) 1991-06-25 US disclosed
US-4980356-A ANTICONVULSANTS; ANTISPASMODIC AGENTS; MUSCULAR AND NERVOUS SYSTEMS DISORDERS RHONE-POULENC SANTE (FR) 1990-12-25 US disclosed
US-4980356-A ANTICONVULSANTS; ANTISPASMODIC AGENTS; MUSCULAR AND NERVOUS SYSTEMS DISORDERS RHONE-POULENC SANTE (FR) 1990-12-25 US disclosed